Weight Bias Is a Problem in Health Care. Here ’ s What Doctors Can Do
Aubrey Gordon still recalls going to the doctor and having her blood pressure checked three times—because the provider couldn’t believe it was normal, given the fact that she’s overweight. Considering the treatment she’s received at doctors’ offices all her life, she wasn’t exactly surprised. “It’s kind of wild to see that my size comes with so many assumptions,” she says. “From the moment I walk in, my fatness is considered a problem to be solved. Even before I speak, there’s bias and misconceptions based on how I look. I’m considered lazy, non-compli...
Source: TIME: Health - February 1, 2023 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized Health Care healthscienceclimate Source Type: news

European Commission approves label expansion of Roche ’s Hemlibra to include people with moderate haemophilia A in the EU
Hemlibra, already approved for severe haemophilia A in the EU, will now also provide an effective and convenient prophylactic treatment option for people with moderate haemophilia AModerate haemophilia A can have a significant impact on the lives of people affected, with only 15% living a bleed-free life1The approval is based on the HAVEN 6 results, whereHemlibra demonstrated effective bleed control and a favourable safety profile in people with moderate haemophilia A without inhibitors2Basel, 01 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission approved the expansion of the He...
Source: Roche Investor Update - February 1, 2023 Category: Pharmaceuticals Source Type: news

European Commission approves label expansion of Roche ’s Hemlibra to include people with moderate haemophilia A in the EU
Hemlibra, already approved for severe haemophilia A in the EU, will now also provide an effective and convenient prophylactic treatment option for people with moderate haemophilia AModerate haemophilia A can have a significant impact on the lives of people affected, with only 15% living a bleed-free life1The approval is based on the HAVEN 6 results, whereHemlibra demonstrated effective bleed control and a favourable safety profile in people with moderate haemophilia A without inhibitors2Basel, 01 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission approved the expansion of the He...
Source: Roche Media News - February 1, 2023 Category: Pharmaceuticals Source Type: news

Asset Management: Stockpickers hope to profit after a decade of pain
Plus, Blackstone’s real estate woes, China bets send base metals soaring and a sublime Sleeping Beauty#blackstone #sleepingbeauty (Source: Reuters: Health)
Source: Reuters: Health - January 30, 2023 Category: Consumer Health News Source Type: news

Janssen Announces Unblinding of Phase 3 CARTITUDE-4 Study of CARVYKTI ® (cilta-cel) as Primary Endpoint Met in Treatment of Patients with Relapsed and Refractory Multiple Myeloma
RARITAN, New Jersey, January 27, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Phase 3 CARTITUDE-4 study evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) versus pomalidomide, bortezomib, and dexamethasone (PVd) or daratumumab, pomalidomide, and dexamethasone (DPd) for the treatment of patients with relapsed and lenalidomide-refractory multiple myeloma met its primary endpoint of significant improvement in progression-free survival (PFS) at the first pre-specified interim analysis. As a result of meeting the primary endpoint, the Independent Data Monitoring Commi...
Source: Johnson and Johnson - January 27, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

Florida biotech co. Pacira Biosciences opens Houston clinician training center
The center will train clinicians in ways to avoid prescribing opioids for pain management. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 25, 2023 Category: Biotechnology Authors: Jishnu Nair Source Type: news

This doctor wants to replace opioids with lasers for pain management
Dr. Scott Sigman, an orthopedic surgeon and sports medicine specialist, has been on a mission for the last decade to find alternatives to opioids for pain management. He thinks he's found the answer in lasers. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 9, 2023 Category: Health Management Authors: Hannah Green Source Type: news

Patient-Centered Texting Platform Beneficial for Interstitial Cystitis
THURSDAY, Jan. 5, 2023 -- A patient-centered text message-based platform can enhance self-efficacy of symptom management for patients with interstitial cystitis/bladder pain syndrome (IC/BPS), according to a study published online Dec. 15 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 5, 2023 Category: Pharmaceuticals Source Type: news

Can New Guidelines Keep Docs From Undertreating Pain? Can New Guidelines Keep Docs From Undertreating Pain?
Art Caplan, PhD, discusses the undertreatment of pain and the need for additional guidelines to improve pain management.Medscape Business of Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 4, 2023 Category: Consumer Health News Tags: Family Medicine/Primary Care Commentary Source Type: news

Physicians React: Right Path Now With Pain Management, Opioids? Physicians React: Right Path Now With Pain Management, Opioids?
Doctors give opinions about whether their profession is being over- or under-aggressive with pain management, especially where prescription of opioids is concerned.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - December 30, 2022 Category: Primary Care Tags: Internal Medicine News Source Type: news

Opioid Prescribing Practices in Chronic Kidney Disease Opioid Prescribing Practices in Chronic Kidney Disease
A new study looks at opioid prescribing patterns for pain management in patients with chronic kidney disease. Are these drugs being prescribed appropriately?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 29, 2022 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

IBD Patients on the Most Effective Ways Doctors Can Treat Their Condition
People who have inflammatory bowel disease (IBD)—which is the umbrella term for Crohn’s disease and ulcerative colitis—often experience a range of symptoms, from intense abdominal cramping and pain to persistent diarrhea and overwhelming fatigue. Living with IBD can significantly disrupt everyday life and make it challenging to maintain physical and mental wellbeing. There’s no cure for IBD—it lasts a lifetime. Like other chronic conditions, IBD can go into remission with effective treatment, but people might still experience occasional flares that make life more difficult. Approximately 1.6 m...
Source: TIME: Health - December 28, 2022 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized Gut health healthscienceclimate Source Type: news

Co-use of cannabis and prescription opioids in adults in the USA: a population-based, cross-sectional analysis of the NHANES from 2009 to 2018 - Diep C, Goel A, Wijeysundera DN, Clarke H, Ladha KS.
INTRODUCTION: Cannabis and cannabinoids continue to gain popularity as adjuncts or alternatives to opioids in pain management, with evolving evidence of effectiveness. The relationship between cannabis and opioid use has previously been investigated in sma... (Source: SafetyLit)
Source: SafetyLit - December 26, 2022 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Tech industry may lead to long-term gains despite short term pain: Gene Goldman
Cetera Investment Management CIO and research director Gene Goldman on his outlook for the tech industry into next year and discusses the Fed’s ‘hawkward’ behavior trying to tackle inflation.#genegoldman (Source: Reuters: Health)
Source: Reuters: Health - December 23, 2022 Category: Consumer Health News Source Type: news

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl
FDA OCI, Dr. David J. Smith, pain management, physician, Julia Ann Oertle, office manager, indictment, scheme, healthcare fraud, manufacture, distribute, adulterated, fentanyl, intrathecal, pumps, stomach, fentanyl, vials, San Diego, unnecessary, oral, opioids, Nevada, compounding, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - December 16, 2022 Category: Medical Law Authors: DOJ Source Type: news